4-Aminopyridine improves real-life gait performance in SCA27B on a single-subject level: a prospective n-of-1 treatment experience

J Neurol. 2023 Nov;270(11):5629-5634. doi: 10.1007/s00415-023-11868-y. Epub 2023 Jul 13.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 4-Aminopyridine* / therapeutic use
  • Gait*
  • Humans
  • Potassium Channel Blockers / therapeutic use
  • Prospective Studies

Substances

  • 4-Aminopyridine
  • Potassium Channel Blockers